SRSF2 and myeloid neoplasm: NGS is essential for this diagnosis, as it enables detection of at least one somatic mutation in genes commonly mutated in myeloid neoplasms (e.g., DNMT3A, TET2, ASXL1, SF3B1, SRSF2, etc.).